NCT02596581

Brief Summary

The aims of the present study were to determine the gingival crevicular fluid (GCF) chemerin and interleukin-6 (IL-6) levels and to analyse the relationship between chemerin and IL-6 in periodontal health and in chronic periodontitis (CP) with and without type 2 diabetes mellitus (T2DM) as well as to evaluate the effect of non-surgical periodontal therapy on the GCF chemerin levels.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2014

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2014

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 2, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 4, 2015

Completed
Last Updated

November 4, 2015

Status Verified

November 1, 2015

Enrollment Period

10 months

First QC Date

November 2, 2015

Last Update Submit

November 3, 2015

Conditions

Keywords

periodontitisdiabetes mellituschemerininterleukin-6

Outcome Measures

Primary Outcomes (1)

  • gingival crevicular fluid chemerin level

    gingival crevicular fluid chemerin levels change from baseline to at 8th weeks

    8th weeks

Secondary Outcomes (5)

  • Interleukin-6

    8th weeks

  • gingival index

    8ths week

  • plaque index

    8ths week

  • bleeding on probing

    8th weeks

  • clinical attachment level

    8th weeks

Study Arms (4)

diabetics with periodontally healthy group

NO INTERVENTION

Control group

systemically and periodontally healthy group

NO INTERVENTION

Control group

diabetics with chronic periodontitis group

ACTIVE COMPARATOR

non-surgical periodontal treatment was performed

Other: non-surgical periodontal treatment

chronic periodontitis group

ACTIVE COMPARATOR

non-surgical periodontal treatment was performed

Other: non-surgical periodontal treatment

Interventions

scaling and root planing were performed

chronic periodontitis groupdiabetics with chronic periodontitis group

Eligibility Criteria

Age35 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Diabetic subjects should have T2DM and had no any known systemic diseases other than T2DM
  • Subjects who had HbA1c levels \< 8% and ≥ 6.5% (well and moderate control)
  • Chronic periodontitis patients had radiographic evidence of bone loss and attachment loss with a minimum of 6 teeth having pocket probing depth (PD) ≥ 5mm in at least 2 different quadrants
  • Control groups were designed as healthy if the full-mouth probing depth (PD) was ≤3mm and bleeding on probing (BOP) score \< %15 at examination and they had no radiographic evidence of alveolar bone loss.

You may not qualify if:

  • Presence of other systemic disorders that could influence the course of periodontal disease; pregnancy, lactation, current and former use of tobacco;
  • Administration of non-steroidal and anti-inflammatory drugs or antibiotic therapies within the previous 6 months;
  • Need for antibiotic prophylaxis for dental treatment and having received non-surgical periodontal treatment within the past 6 months or surgical periodontal treatment within the past 12 months.
  • Subjects who had body mass index (BMI) \>24.9 kg /m2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Chronic PeriodontitisDiabetes MellitusPeriodontitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Umut Ballı, Phd, DDS

    Bülent Ecevit University Faculty of Dentistry

    PRINCIPAL INVESTIGATOR
  • Figen Öngöz Dede, Phd, DDS

    Bülent Ecevit University Faculty of Dentistry

    PRINCIPAL INVESTIGATOR
  • Şeyma Bozkurt Doğan, Phd, DDS

    Bülent Ecevit University Faculty of Dentistry

    STUDY CHAIR
  • Erdim Sertoğlu, MD, DDS

    Elazig Military Hospital, Department of Medical Biochemistry, Elazığ, Turke

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asisstant Proffessor, Bulent Ecevit University

Study Record Dates

First Submitted

November 2, 2015

First Posted

November 4, 2015

Study Start

July 1, 2014

Primary Completion

May 1, 2015

Study Completion

October 1, 2015

Last Updated

November 4, 2015

Record last verified: 2015-11